ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 19 for:    "Burning Mouth Syndrome"

Acupuncture Versus Clonazepam in Burning Mouth Syndrome (ACUCLONBMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02382029
Recruitment Status : Completed
First Posted : March 6, 2015
Last Update Posted : March 6, 2015
Sponsor:
Information provided by (Responsible Party):
Vanja Vucicevic Boras, University of Zagreb

Brief Summary:

Objective: Burning mouth syndrome (BMS) is chronic oral condition characterized with burning symptoms which affects perimenopausal and postmenopausal women. It seems that neuropathy might be the underlying cause of the condition. There are still insufficient data regarding successful therapy. The aim of this study was to compare efficacy of acupuncture and clonazepam in 42 BMS patients (38 women, 4 men), age range 66.7±12 years.

Methods: Patients were randomly divided into two groups. Acupuncture was performed in group I during four weeks, 3 times per week on the points ST 8, GB 2, TB 21, SI 19, SI 18, LI 4 on both sides of the body as well as GV 20, each session lasted half an hour.Group II patients took clonazepam two times a day (0.5 mg) in the morning and after two weeks two tablets (0.5 mg) in the morning and in the evening during the next two weeks. Prior to and one month after either therapy, participants fulfilled questionnaires: visual analogue scale, Beck depression inventory, LANSS pain scale, 36-item short form Health Survey (SF-36) and Montreal Cognitive Assessment (MoCA). Statistical analysis was performed by use of Student t test and Pearson's correlation test. P values lower than 0.05 were considered significant.


Condition or disease Intervention/treatment Phase
Burning Mouth Syndrome Drug: Clonazepam Other: acupuncture Early Phase 1

Detailed Description:

This study was approved by Ethical Committee of the School of dentistry in Zagreb. Prior to the study every participant signed informed consent according to the Helsinki II. All patient were recruited from the Department of Oral medicine, School of dentistry in Zagreb.

Patients were randomized by simple randomization method- flipping a coin (heads - acupuncture, tails - clonazepam).

Inclusion criteria were symptoms of burning in the oral cavity with clinically healthy appearance of the oral mucosa. Burning symptoms were continuous throughout the day and lasted for more than 6 months. Some of the patients also had hyposalivation and disturbed taste.

Prior to the either therapy as well as after the therapy (one month after the therapy has finished) every participant fulfilled following questionnaires: visual analogue scale (VAS) which referred to the severity of burning symptoms, Beck depression inventory (BDI), The Leeds assessment of neuropathic symptoms and signs (LANSS) Pain Scale, 36-item short form Health Survey (SF-36) total sum score and Montreal Cognitive Assessment (MoCA).

Arm (I) traditional Chinese acupuncture - performed 3 times during one week for four weeks on the points ST 8 (stomach- tou wei), GB 2, TE 21, SI 19 (small intestine- ting gong), SI 18 (small intestine- quan liao), LI 4 (large intestine-Yuan) on both sides of the body as well as GV 20 (Governing vessel-bai hui) and each session lasted half an hour. We used sterile acupuncture needles from surgical stainless steel silicone coated with spring handle, the dimensiones of the chosen needles were 0.25 in diameter and 30 mm lenght, inserted at the depht of the 0.5-1 cun. The elicited response was of the type "de qi" accompanied by redness and a feeling of numbness around the needles.

Arm (II) Clonazepam - patients took clonazepam two times a day (0.5 mg) in the morning and after two weeks one tablet (0.5 mg) in the morning and another tablet (0.5 mg) in the evening during the next two weeks.

Statistical analysis was performed by use of Student t test and Pearson's correlation test. P values lower than 0.05 were considered significant.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 4 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: The Effectiveness of Acupuncture Versus Clonazepam in the Patients With Burning Mouth Syndrome
Study Start Date : March 2014
Actual Primary Completion Date : November 2014
Actual Study Completion Date : November 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acupuncture Burns
Drug Information available for: Clonazepam

Arm Intervention/treatment
Active Comparator: clonazepam
Twenty two patients took clonazepam two times a day (0.5 mg) in the morning and after two weeks one tablet (0.5 mg) in the morning and another tablet (0.5 mg) in the evening during the next two weeks.
Drug: Clonazepam
Active medical treatment for burning mouth syndrome
Other Name: Rivotril

Experimental: acupuncture

Traditional Chinese acupuncture was performed on 20 participants 3 times during one week for four weeks. Intervention was performed on acupuncture points as follows: the points ST 8 (stomach- tou wei), GB 2, TE 21, SI 19 (small intestine- ting gong), SI 18 (small intestine- quan liao), LI 4 (large intestine-Yuan) on both sides of the body as well as GV 20 (Governing vessel-bai hui).

Each session lasted half an hour. Sterile acupuncture needles made from surgical stainless steel silicone coated with spring handle were used. The dimensions of the chosen needles were 0.25 in diameter and 30 mm length, inserted at the depth of the 0.5-1 cm. The elicited response was of the type "de qi" accompanied by redness and a feeling of numbness around the needles.

Other: acupuncture
Traditional chinese acupuncture




Primary Outcome Measures :
  1. Pain intensity [ Time Frame: 6 months ]
    Pain intensity measured by the visual analogue scale


Secondary Outcome Measures :
  1. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale [ Time Frame: 6 months ]
    Assessment of neuropathic pain measured by validated instrument (LANSS pain scale)

  2. Cognitive function [ Time Frame: 6 months ]
    Assesment of cognitive function measured by validated instrument ( MoCA cognitive test)

  3. Depression [ Time Frame: 6 months ]
    Assesment of depressive symptoms by use of validated instrument (Beck Depression Inventory)

  4. Quality of life [ Time Frame: 6 months ]
    Assesment of quality of life by validated instrument (Short Forma Health Survey: SF-36)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Clinical diagnosis of burning mouth syndrome Clinically normal appearance of oral mucosa Must be able to swallow tablets

Exclusion Criteria:

Oral mucosal lesions Anemia


Responsible Party: Vanja Vucicevic Boras, Associate professor, University of Zagreb
ClinicalTrials.gov Identifier: NCT02382029     History of Changes
Other Study ID Numbers: UZagreb
First Posted: March 6, 2015    Key Record Dates
Last Update Posted: March 6, 2015
Last Verified: March 2015

Additional relevant MeSH terms:
Burning Mouth Syndrome
Syndrome
Burns
Disease
Pathologic Processes
Wounds and Injuries
Mouth Diseases
Stomatognathic Diseases
Clonazepam
Anticonvulsants
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs